| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/07/2008 | US7432377 of preparing 4-substituted quinoline compounds as intermediates in the manufacture of receptor tyrosine kinase inhibitors and intermediate compounds used in the methods thereof, wherein the 4-substituted quinoline compound has the following general formula (I): |
| 10/07/2008 | US7432375 JNK inhibitors |
| 10/07/2008 | US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 10/07/2008 | US7432373 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 10/07/2008 | US7432372 Fluorinated resorufin compounds and their application |
| 10/07/2008 | US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying |
| 10/07/2008 | US7432369 Pyridyl-substituted porphyrin compounds and methods of use thereof |
| 10/07/2008 | US7432368 Photolabile protecting groups |
| 10/07/2008 | US7432366 Moraxella catarrhalis BASB034 polypeptides and used thereof |
| 10/07/2008 | US7432361 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis |
| 10/07/2008 | US7432358 Oncogene, recombinant protein derived therefrom, and uses thereof |
| 10/07/2008 | US7432344 Porcine CTLA-4 for xenograft-specific immunosuppression |
| 10/07/2008 | US7432307 Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation |
| 10/07/2008 | US7432306 Method for preparing novel transcription factors and use |
| 10/07/2008 | US7432305 Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 10/07/2008 | US7432304 Providing cell which overexpresses a Bcl-2 family protein; gossypol compound; treating with cell with an effective amount of gossypol compound under conditions such that apoptosis in cell is modulated |
| 10/07/2008 | US7432303 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 10/07/2008 | US7432302 Treating proliferative cutaneous disease using a polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; e.g. lupus; use with other biosynthesis enzyme inhibitors |
| 10/07/2008 | US7432301 Use of S-nitrosothiol signaling to treat disordered control of breathing |
| 10/07/2008 | US7432300 Gossypol co-crystals and the use thereof |
| 10/07/2008 | US7432299 Use of alpha-2-delta ligands such as gabapentin, pregabalin and other alpha-2-delta ligands such as [6-(Aminomethyl)bicyclo[3.2.0]hept-6-yl]acetic acid; treatment of premature ejaculation |
| 10/07/2008 | US7432298 Fluorescent polymeric materials containing lipid soluble rhodamine dyes |
| 10/07/2008 | US7432297 composition is obtained by reacting resorcin, formaldehyde and methyl ethyl ketone in the presence of water, salts and acidic catalyst; adhesive for adhering wood with other organic materials and the like |
| 10/07/2008 | US7432296 Pharmaceutical formulations containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds |
| 10/07/2008 | US7432295 18F fluorine compounds, especially N-fluoroalkyl- or fluoroalkenylene-substituted 2-(2-Nitro-1H-imidazol-1-yl)acetamides, useful for non-invasive imaging techniques such as PET |
| 10/07/2008 | US7432294 Ritonavir or a combination of ritonavir and another HIV protease inhibitor such as indinavair, saquinavir, nelfinavir etc., a long chain fatty acid, propylen glycol or ethanol, water and a surfactant; improved solubiity |
| 10/07/2008 | US7432293 Heterocyclic compounds useful as Nurr-1 activators |
| 10/07/2008 | US7432292 Anticancer agents; autoimmune diseases; antiinflammatory agents; ; graft versus host disease; Crohn's diseases; skin disorders |
| 10/07/2008 | US7432291 Anticancer, antitumor agents; compounds are 1-(2-(phenethenyl)oxazol-4-ylmethoxy)-4-(1,2,3-triazolylethoxymethyl)-benzenes or corresponding derivatives where oxazole is replaced by thiazole |
| 10/07/2008 | US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944 |
| 10/07/2008 | US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors |
| 10/07/2008 | US7432288 Pyrrole-2,5-dione derivatives as Liver X receptor modulators |
| 10/07/2008 | US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |
| 10/07/2008 | US7432286 Pharmaceutically active sulfonyl hydrazide derivatives |
| 10/07/2008 | US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 10/07/2008 | US7432284 Estrogen receptor modulators |
| 10/07/2008 | US7432283 Heterocyclic GABAA subtype selective receptor modulators |
| 10/07/2008 | US7432282 3-{4-[(5-bromopyridin-3-ylmethyl)amino]butyl}-1H-indole-5-carbonitrile; neuroleptics and/or antihypertensives; bioavailability; absorbability |
| 10/07/2008 | US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist |
| 10/07/2008 | US7432280 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake |
| 10/07/2008 | US7432279 serine/threonine protein kinases inhibitors, TNF- alpha synthesis inhibitors; antiinflammatory agents; rheumatoid arthritis; 4-(3-chloro-4-fluorophenylamino)-6-(pyridin-3-ylmethylamino)-1,7-naphthyridine-3-carbonitrile; oral adminitration; small molecules |
| 10/07/2008 | US7432278 Dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines as antiprotozoal agents |
| 10/07/2008 | US7432277 Phosphorus-containing macrocycles |
| 10/07/2008 | US7432276 amino(4-methoxy-7,7-dimethyl(7,12,12a,6a-tetrahydrochromano[4,3-b]quinolin-9-yl))methane-1-thione; increasing cellular ATP binding cassette transporter ABCA1 production ; reduces cholesterol deposition in coronary arteries; coronary artery diseases, dyslipidiemias and metabolic syndrome |
| 10/07/2008 | US7432275 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 10/07/2008 | US7432274 e.g., R)-9-[2-(Stearoyloxymethyl)- and (R)-9-[2-(Myristoyloxymethyl)-4-(L-valyloxy)butyl]guanine; treatment or prophylaxis of viral infections such as those caused by Varicella zoster, Herpes, Epstein-Barr SIV, HIV-1 or HIV-2. |
| 10/07/2008 | US7432273 cancer and/or viral infection, leukemia; improved pharmacological properties; oral bioavailability, greater potency, extended half-life in vivo, Side effects reduction; 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-6-diethoxy-phosphoryl)-hexanoic acid, diethyl cyano phosphonate |
| 10/07/2008 | US7432272 Pharmacokinetic properties, including improved oral bioavailability, greater potency and extended effective drug biological half-life in vivo; inhibiting RNA-dependent RNA polymerase, infections |
| 10/07/2008 | US7432271 Atherosclerosis; anticholesterol agents; cardiovascular disorders; stroke; thrombosis; hypotensive agents; restenosis; antidiabetic agents; antiarthritic agents; anticancer agnets; inflammatory bowel disorders |
| 10/07/2008 | US7432270 N-aroyl cyclic amines |
| 10/07/2008 | US7432269 Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents |
| 10/07/2008 | US7432268 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 10/07/2008 | US7432267 imidazo(1,5-a)-pyrazine-1,3-dione derivatives; Anticancer agents; immune disorders; (5S,8S,8aR)-4-[Octahydro-7-[(1,1-dimethylethoxy)carbonyl]-1,3-dioxo-5,8-methanoimidazo[1,5-a]pyrazin-2-yl]-2-(trifluoromethyl)benzonitrile |
| 10/07/2008 | US7432266 Phosphodiesterase 4 inhibitors |
| 10/07/2008 | US7432265 Imidazopyrazines as cyclin dependent kinase inhibitors |
| 10/07/2008 | US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain |
| 10/07/2008 | US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 10/07/2008 | US7432262 Use of these dipeptidylpeptidase-IV inhibitors; treating type I and II diabetes mellitus, arthritis, obesity, allograft transplantation, or calcitonin-induced osteoporosis; 2-amino-imidazo[4,5-d]pyridazine-4,7-diones |
| 10/07/2008 | US7432261 Improved pharmacokinetic properties, activity, oral bioavailability, potency, effective half-lives in vivo; fewer side effects; attaining high concentrations of phosphonate-containing molecules in target cells |
| 10/07/2008 | US7432260 Pyrimidine compounds |
| 10/07/2008 | US7432259 Spiro-piperidine derivatives |
| 10/07/2008 | US7432258 4'-[(1R)-1-[[(6,7-dichloro-3-oxo-2,3-dihydro-4H-1,4-benzoxazin- 4-yl)acetyl](methyl)amino]-2-(4-morpholinyl)ethyl]-4-biphenylcarboxylic acid; as antagonists of urotensin II, congestive heart failure, stroke, ischemic heart disease (e.g. angina, myocardial ischemia), cardiac arrhythmia, hypertension |
| 10/07/2008 | US7432257 Piperdinyl-phenoxazine and phenothiazine derivatives as δ-opioid modulators |
| 10/07/2008 | US7432256 Substitued imidazo [1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives |
| 10/07/2008 | US7432255 Histamine 3 receptor antagonists/inverse agonists ; (4-isopropyl-piperazin-1-yl)-[1-(1-isopropyl-pyrrolidin-3-yl)-1H-indol-5-yl]-methanone; obesity, metabolic syndrome (syndrome X), and other eating disorders |
| 10/07/2008 | US7432254 Method for treating glaucoma IC |
| 10/07/2008 | US7432253 Phosphoepoxides, method for making same and uses |
| 10/07/2008 | US7432252 Method of promoting cervical and vaginal secretions |
| 10/07/2008 | US7432251 Replenishing diseased, damaged, or destroyed neural cells in the central nervous system or in the peripheral nervous system; recruitment of neuronal progenitors in diseased areas of the nervous system can be considerably enhanced |
| 10/07/2008 | US7432250 Oligoribonucleotides and ribonucleases for cleaving RNA |
| 10/07/2008 | US7432249 Oligoribonucleotides and ribonucleases for cleaving RNA |
| 10/07/2008 | US7432248 6-Oxyamino-7-deazapurin-9-yl-2-substituted ribofuranose derivatives, e.g., 1-(6-hydroxylamino-7-ethenyl-7-deazapurin-9-yl)-2-methyl- beta -D-ribofuranose; treating viral infections mediated by a virus in the flaviviridae family |
| 10/07/2008 | US7432247 Used to decrease the amount of inotrope needed after trauma or surgery |
| 10/07/2008 | US7432240 Fumaric acid amides |
| 10/07/2008 | US7432239 Polyoxyalkylene compound and method for making |
| 10/07/2008 | US7432067 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility |
| 10/07/2008 | US7431953 Topical antiallergenic cream containing Asian longhorn beetle wastes; animal extracts |
| 10/07/2008 | US7431948 Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 10/07/2008 | US7431944 One-a-day, oral administration of a methylphenidate drug, e,g, Ritalin, the dosage of which form provides an immediate dose upon ingestion followed by release of more dose(s) later; particles uncoated/coated with ammonio methacrylate |
| 10/07/2008 | US7431943 Controlled release and taste masking oral pharmaceutical compositions |
| 10/07/2008 | US7431942 Orally disintegrable tablets |
| 10/07/2008 | US7431941 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 10/07/2008 | US7431940 Methods for treatment of human skin damaged by laser treatment or chemical peelings and compositions useful in such methods |
| 10/07/2008 | US7431939 Inhibition of systemic infections in humans and vertebrates by dietary fibers |
| 10/07/2008 | US7431922 Bioadhesive directed somatic cell therapy |
| 10/07/2008 | US7431921 Interferon beta-like molecules |
| 10/07/2008 | US7431916 Simultaneous inhalation delivery of at least two drugs with high efficiency to targeted airways and/or lungs |
| 10/07/2008 | US7431710 Ocular implants with anchors and methods thereof |
| 10/07/2008 | CA2482124C Methods of treatment using an epithelial sodium channel blocker and an inhibitor of the mineralocorticoid receptor |
| 10/07/2008 | CA2444071C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 10/07/2008 | CA2435946C Piperidine derivatives as neurokinin 1 antagonists |
| 10/07/2008 | CA2433772C Pyrimidine matrix metalloproteinase inhibitors |
| 10/07/2008 | CA2427573C Indole derivatives as pde5-inhibitors |
| 10/07/2008 | CA2426009C Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles |
| 10/07/2008 | CA2419147C Fill liquid composition for ibuprofen capsule and capsule preparation |
| 10/07/2008 | CA2416685C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 10/07/2008 | CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives |
| 10/07/2008 | CA2410232C Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer |
| 10/07/2008 | CA2399464C Drug delivery apparatus |
| 10/07/2008 | CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants |